Cargando…
iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid development, especially use against hematologic malignancies. Clinical trials of NK cell-based adoptive transfer to treat relapsed or refractory malignancies have used peripheral blood, umbilical cord blood and plu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851389/ https://www.ncbi.nlm.nih.gov/pubmed/35185932 http://dx.doi.org/10.3389/fimmu.2022.841107 |